Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY):a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial (vol 397, pg 475, 2021)

被引：0
|
作者：
Gordon, K. B.
Foley, P.
Krueger, J. G.
机构：
来源：
LANCET | 2021年 / 397卷 / 10280期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1182 / 1182
页数：1
相关论文
共 50 条
  • [41] Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial
    Vaclavkova, Andrea
    Chimenti, Sergio
    Arenberger, Petr
    Hollo, Peter
    Sator, Paul-Gunther
    Burcklen, Michel
    Stefani, Mylene
    D'Ambrosio, Daniele
    [J]. LANCET, 2014, 384 (9959): : 2036 - 2045
  • [42] Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study
    Van Voorhees, Abby S.
    Gold, Linda Stein
    Lebwohl, Mark
    Strober, Bruce
    Lynde, Charles
    Tyring, Stephen
    Cauthen, Ashley
    Sofen, Howard
    Zhang, Zuoshun
    Paris, Maria
    Wang, Yao
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 96 - 103
  • [43] Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trial
    Chen, Ruchong
    Wei, Liping
    Dai, Yuanrong
    Wang, Zaiyi
    Yang, Danrong
    Jin, Meiling
    Xiong, Cui
    Li, Ting
    Hu, Shuling
    Song, Jie
    Chan, Robert
    Kumar, Subramanya
    Abdelkarim, Azza
    Zhong, Nanshan
    [J]. ERJ OPEN RESEARCH, 2024, 10 (03)
  • [44] Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
    Merola, Joseph F.
    Parish, Lawrence Charles
    Guenther, Lyn
    Lynde, Charles
    Lacour, Jean -Philippe
    Staubach, Petra
    Cheng, Sue
    Paris, Maria
    Picard, Hernan
    Deignan, Cynthia
    Jardon, Shauna
    Chen, Mindy
    Papp, Kim A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 485 - 493
  • [45] Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study
    Gebauer, Kurt
    Spelman, Lynda
    Yamauchi, Paul S.
    Bagel, Jerry
    Nishandar, Tushar
    Crane, Michael
    Kopeloff, Iris
    Kothekar, Mudgal
    Yao, Siu-Long
    Sofen, Howard L.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (01) : 91 - 99
  • [46] EFFICACY AND SAFETY OF PRUCALOPRIDE IN MEN WITH CHRONIC CONSTIPATION: A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Yiannakou, Y.
    Bouchoucha, M.
    Schiefke, I.
    Piessevaux, H.
    Filip, R.
    Gabalec, L.
    Stephenson, D.
    Kerstens, R.
    Etherson, K.
    Levine, A.
    [J]. GUT, 2015, 64 : A323 - A324
  • [47] Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study
    Dogra, Sunil
    Krupashankar
    Budamakuntla, Leelavathy
    Srinivas, C. R.
    Khopkar, Uday
    Gupta, Sandesh
    Shetty, Narendra
    Pratap, Dasiga Venkata Subrahmanya
    Gopal, M. G.
    Rao, T. Narayana
    Garg, Vijay
    Sumathy, T. K.
    Saraswat, Abir
    Bhat, Ramesh
    Kura, Mahendra
    Pandey, Neeraj
    Shah, Radha
    Krishna, Kotla Sai
    Padmaja, Dalavai
    Manmohan, G.
    Ramakrishnan, M. S.
    Barve, Abhijit
    Montero, Enrique
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (02) : 331 - 333
  • [48] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Zhao, Yan
    Wu, Liming
    Lu, Qianjin
    Gao, Xinghua
    Zhu, Xiaohong
    Yao, Xu
    Li, Linfeng
    Li, Wei
    Ding, Yangfeng
    Song, Zhiqiang
    Liu, Lingling
    Dang, Ningning
    Zhang, Chunlei
    Liu, Xiaoming
    Gu, Jun
    Wang, Jinyan
    Geng, Songhai
    Liu, Qunazhong
    Guo, Yifeng
    Lv, Dong
    Ren, Gong
    Yang, Xiumin
    Deng, Danqi
    Li, Shanshan
    Han, Xiuping
    Biao, Shuzhen
    Zheng, Min
    Dong, Li
    Su, Huijuan
    Bai, Lili
    O'Malley, John T.
    Luo, Junxiang
    Zhang, Jianzhong
    [J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58
  • [49] Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial
    Yang Hai-zhen
    Wang Ke
    Jin Hong-zhong
    Gao Tian-wen
    Xiao Sheng-xiang
    Xu Jin-hua
    Wang Bao-xi
    Zhang Fu-ren
    Li Chun-yang
    Liu Xiao-ming
    Tu Cai-xia
    Ji Su-zhen
    Shen Yang
    Zhu Xue-jun
    [J]. CHINESE MEDICAL JOURNAL, 2012, 125 (11) : 1845 - 1851
  • [50] Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet Efficacy and Safety Results From REACH, a Randomized, Placebo-Controlled, Double-blind Trial
    Leonardi, Craig
    Langley, Richard G.
    Papp, Kim
    Tyring, Stephen K.
    Wasel, Norman
    Vender, Ronald
    Unnebrink, Kristina
    Gupta, Shiraz R.
    Valdecantos, Wendell C.
    Bagel, Jerry
    [J]. ARCHIVES OF DERMATOLOGY, 2011, 147 (04) : 429 - 436
12345